Business Experience in Implementing an Advanced Telemonitoring Service. Valdivieso Martinez B. eHealth week 2010 (Barcelona: CCIB Convention Centre; 2010)
The Role of Health Services Research in a Learning Healthcare SystemAcademyHealth
Dr. David Atkins, U.S. Department of Veterans Affairs, presented at AcademyHealth's 2012 Capitol Hill briefing entitled "Health and the Deficit: Using Health Services Research to Reduce Costs and Improve Quality."
Material de (1) la conferencia “La E-Salud en mundo global” realizada el 17 de febrero de 2.012 por el Sr. Joan Cornet, Presidente Ejecutivo de la Fundación TicSalud (1er ciclo de conferencias en el ámbito TIC-Salud organizado por las Escuelas Universitarias de Informática y de Enfermería con la colaboración de la Fundación Tic-Salud, en el marco del Máster Oficial en Gestión de la Información y el Conocimiento en el Ámbito de la Salud)
La ciencia y la tecnología no tienen fronteras en un mundo global en el que están apareciendo innovaciones por todas partes. La eSalud tiene por vocación dar mejores servicios en el seno de los sistemas de salud. A pesar de las diferencias culturales, lingüísticas y de práctica de la medicina, el ser humano y la salud se convierten en lo mismo en todas partes. Las nuevas tecnologías permiten la comunicación rápida, la compartición de experiencias, el aprendizaje de las mejores prácticas y el contraste de resultados. Por eso la implementación de procesos de eSalud es un fenómeno de alcance local, pero su éxito depende del conocimiento global. Es por ello que cada vez hay más redes y organizaciones que facilitan la transferencia de conocimiento y el compilado de las mejores prácticas. El reto, pues, tanto para las organizaciones sanitarias como para las universidades y empresas innovadoras es lograr que las TICs, una vez probadas y homologadas, sean implementadas en los servicios de salud. Todo un reto tecnológico, legal, ético y financiero.
La conferencia fue impartida por el Sr. Joan Cornet, Presidente Ejecutivo de la Fundación TicSalud. El Sr. Cornet es Ingeniero técnico y Licenciado en psicología. A lo largo de su dilatada experiencia profesional, ha ocupado los cargos de Presidente Consorcio Hospitalario de Cataluña, Vicepresidente de la Federación de Municipios de Cataluña y Coordinador de la Comisión de Sanidad y Servicios Sociales de la FEMP, alto funcionario en la Comisión Europea , y Secretario General del Departamento de Salud de la Generalitat de Catalunya. En septiembre 2005 el Gobierno le encargó la puesta en marcha de la Bioregión de Cataluña y desde Enero 2007 por encargo del Departamento de Salud está al frente de la Fundación TicSalut.
About Marillac Clinic - Grand Junction, Colorado
Clinic Eligibility
• 200% of federal poverty level
• Mesa County residents
• Medical program serves
uninsured ages 18-64
• Dental program serves uninsured,
CHP+, and Medicaid.
The Role of Health Services Research in a Learning Healthcare SystemAcademyHealth
Dr. David Atkins, U.S. Department of Veterans Affairs, presented at AcademyHealth's 2012 Capitol Hill briefing entitled "Health and the Deficit: Using Health Services Research to Reduce Costs and Improve Quality."
Material de (1) la conferencia “La E-Salud en mundo global” realizada el 17 de febrero de 2.012 por el Sr. Joan Cornet, Presidente Ejecutivo de la Fundación TicSalud (1er ciclo de conferencias en el ámbito TIC-Salud organizado por las Escuelas Universitarias de Informática y de Enfermería con la colaboración de la Fundación Tic-Salud, en el marco del Máster Oficial en Gestión de la Información y el Conocimiento en el Ámbito de la Salud)
La ciencia y la tecnología no tienen fronteras en un mundo global en el que están apareciendo innovaciones por todas partes. La eSalud tiene por vocación dar mejores servicios en el seno de los sistemas de salud. A pesar de las diferencias culturales, lingüísticas y de práctica de la medicina, el ser humano y la salud se convierten en lo mismo en todas partes. Las nuevas tecnologías permiten la comunicación rápida, la compartición de experiencias, el aprendizaje de las mejores prácticas y el contraste de resultados. Por eso la implementación de procesos de eSalud es un fenómeno de alcance local, pero su éxito depende del conocimiento global. Es por ello que cada vez hay más redes y organizaciones que facilitan la transferencia de conocimiento y el compilado de las mejores prácticas. El reto, pues, tanto para las organizaciones sanitarias como para las universidades y empresas innovadoras es lograr que las TICs, una vez probadas y homologadas, sean implementadas en los servicios de salud. Todo un reto tecnológico, legal, ético y financiero.
La conferencia fue impartida por el Sr. Joan Cornet, Presidente Ejecutivo de la Fundación TicSalud. El Sr. Cornet es Ingeniero técnico y Licenciado en psicología. A lo largo de su dilatada experiencia profesional, ha ocupado los cargos de Presidente Consorcio Hospitalario de Cataluña, Vicepresidente de la Federación de Municipios de Cataluña y Coordinador de la Comisión de Sanidad y Servicios Sociales de la FEMP, alto funcionario en la Comisión Europea , y Secretario General del Departamento de Salud de la Generalitat de Catalunya. En septiembre 2005 el Gobierno le encargó la puesta en marcha de la Bioregión de Cataluña y desde Enero 2007 por encargo del Departamento de Salud está al frente de la Fundación TicSalut.
About Marillac Clinic - Grand Junction, Colorado
Clinic Eligibility
• 200% of federal poverty level
• Mesa County residents
• Medical program serves
uninsured ages 18-64
• Dental program serves uninsured,
CHP+, and Medicaid.
John Ainsworth, a Research Fellow at The University of Manchester, and member of Manchester mHealth ecosystem introduces m-health and how it has been successful in monitoring mental health patients.
Presentation given at the Sidney R Garfield Center for Health Care Innovation, with other colleagues, on the potential for integrating social media into an integrated care system.
Soccnx III - Using Social for social good - the case for Social Business in H...LetsConnect
Speakers: Bill Looby
"Social Business for Healthcare Social is everywhere. Patients and providers are living in a socially networked world. Healthcare is a social business. Are you ready? Social businesses leverage collaboration capabilities to connect people and break down traditional boundaries. They activate networks of people that apply relevant content and expertise to improve and accelerate how work gets done. This is a demonstration of social business capabilities applied to healthcare for improved patient outcomes and efficiency of care delivery. See examples of connecting providers across acute and ambulatory care settings in new ways via social business technologies and open standards. Featured technologies include IBM Connections social business software for healthcare and IBM InfoSphere® HC solutions built on Initiate® technology.
DASH - does arthritis self-management help?epicyclops
This lecture was given by Dr Marta Buszewicz, General Practitioner from North London and Senior Lecturer in Community Based Teaching & Research at UCL, to the North British Pain Association Spring Scientific Meeting in Edinburgh on Friday 18th May, 2007. Her lecture forms part of a conference "Blurring the Boundaries - Managing Pain in Primary Care and Secondary Care".
The 10 most influential multispecialty hospital smallinsightscare
We bring you some of the prominent multispecialty hospitals through our issue, “10 Most Influential Multispecialty Hospitals to Watch.” These hospitals are truly revolutionizing the way we care, by keeping themselves abreast with latest technology and therapies.
The Broad Picture - recent developments in long-term condition managmentepicyclops
This lecture was given by Dr Aileen Keel, Deputy Chief Medical Officer for Scotland, to the North British Pain Association Spring Scientific Meeting on Friday 18th May, 2007 and forms part of a conference "Blurring the Boundaries - Managing Pain in Primary Care and Secondary Care".
Reproduced with permission.
Presentation given at Service Science Factory, Cafe october 2013. The presentation mainly deals with data/information from a user experience point of view in the healthcare settings. And suggests patient centric services based on key meta trends in the sector.
John Ainsworth, a Research Fellow at The University of Manchester, and member of Manchester mHealth ecosystem introduces m-health and how it has been successful in monitoring mental health patients.
Presentation given at the Sidney R Garfield Center for Health Care Innovation, with other colleagues, on the potential for integrating social media into an integrated care system.
Soccnx III - Using Social for social good - the case for Social Business in H...LetsConnect
Speakers: Bill Looby
"Social Business for Healthcare Social is everywhere. Patients and providers are living in a socially networked world. Healthcare is a social business. Are you ready? Social businesses leverage collaboration capabilities to connect people and break down traditional boundaries. They activate networks of people that apply relevant content and expertise to improve and accelerate how work gets done. This is a demonstration of social business capabilities applied to healthcare for improved patient outcomes and efficiency of care delivery. See examples of connecting providers across acute and ambulatory care settings in new ways via social business technologies and open standards. Featured technologies include IBM Connections social business software for healthcare and IBM InfoSphere® HC solutions built on Initiate® technology.
DASH - does arthritis self-management help?epicyclops
This lecture was given by Dr Marta Buszewicz, General Practitioner from North London and Senior Lecturer in Community Based Teaching & Research at UCL, to the North British Pain Association Spring Scientific Meeting in Edinburgh on Friday 18th May, 2007. Her lecture forms part of a conference "Blurring the Boundaries - Managing Pain in Primary Care and Secondary Care".
The 10 most influential multispecialty hospital smallinsightscare
We bring you some of the prominent multispecialty hospitals through our issue, “10 Most Influential Multispecialty Hospitals to Watch.” These hospitals are truly revolutionizing the way we care, by keeping themselves abreast with latest technology and therapies.
The Broad Picture - recent developments in long-term condition managmentepicyclops
This lecture was given by Dr Aileen Keel, Deputy Chief Medical Officer for Scotland, to the North British Pain Association Spring Scientific Meeting on Friday 18th May, 2007 and forms part of a conference "Blurring the Boundaries - Managing Pain in Primary Care and Secondary Care".
Reproduced with permission.
Presentation given at Service Science Factory, Cafe october 2013. The presentation mainly deals with data/information from a user experience point of view in the healthcare settings. And suggests patient centric services based on key meta trends in the sector.
Brightpoint Health Leaders Address US Conference on AIDS on the need for Inte...lsolomon212
At the recent US Conference on AIDS, three leaders from Brightpoint Health: President and CEO Paul Vitale, Chief Clinical Officer Barbara Zeller, MD and Jessica Diamond, SVP Organizational Culture and Quality, discussed Brightpoint's evolution from an AIDS residential facility to a Federally Qualified Health Center; how health care models are being reinvented to drive efficiency and accountability and how Brightpoint has succeeded in tackling some of toughest challenges: how do we best implement change and how do we pay for it?
Maureen Bisognano: An international perspective: Leading for better health careThe King's Fund
Maureen Bisognano, President and CEO, Institute for Healthcare Improvement, gives an international perspective on leading for better healthcare at The King's Fund Second Annual NHS leadership and Management Summit.
A Vision for U.S. Healthcare's Radical MakeoverCognizant
The healthcare industry is on the verge of a disruptive change that will significantly reshape our experiences and reorient our expectations across the provider and payer value chain.
Multidisciplinary care: a perspective from diagnosis and treatment of rare cancers. Casali P. Technical Conference: Multidisciplinary Care in Cancer as a model of health care quality (Madrid: Ministry of Health and Social Policy, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Sánchez de Toledo J. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Ortiz H. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Barnadas A. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
Experiencias y percepción de la atención integral de los pacientes con cáncer. Oriol Díaz de Bustamante I. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
Experiencias y percepción de la atención integral de los pacientes con cáncer. Moreno Marín P. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Medina JA. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
Experiencias y percepción de la atención integral de los pacientes con cáncer. Fisas Armengol A. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Ferro T. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Díaz Mediavilla J. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
La mejor evidencia junto a la mejor organización: el reto de la coordinación profesional en atención oncológica. Ignacio A. Jornada Técnica: Atención Multidisciplinar en Cáncer como modelo de calidad asistencial (Madrid: Ministerio de Sanidad y Política Social, 2010)
The power of lifestyle interventions to prevent cardiovascular diseases. Tuomilehto J. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
Alcohol and chronic diseases: complex relations. Guillemont J. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
Risk Assessment and Management of Cardiovascular Diseases - an English Approach. Lynam E. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
Cardiovascular disease inequalities: causes and consequences. Capewell S. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
Addressing cardiovascular disease at EU level: tangible plans for the future. Hübel M. Conference on Cardiovascular Diseases (Madrid: Ministry of Health and Social Policy; 2010).
The impact of eHealth on Healthcare Professionals and Organisations: The Impact of ICT at Kaiser Permanente. Wiesenthal A. eHealth week 2010 (Barcelona: CCIB Convention Centre; 2010)
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Business Experience in Implementing an Advanced Telemonitoring Service
1. The Challenge:
“Improving Care Condition”
Dr. Bernardo Valdivieso Martinez,
Quality Manager & Planning Director
Department of Health La Fe, Valencia, Spain
3. Sumary
The introduction
The problem
The solution
Lessons & learnt
4. An introduction
Spain Valencia land
Population: 4.396.318
> 65 years old: 17,3%
Health System:
Hospitals: 28
Primary Care Centres: 500
Budget: (million €)
3.074 (36,9%)
5. An introduction
Valencia land Health Department LA FE
• Atraction 52%
• Population: 260.000
• > 65 years old: 17,3%
• Health System
• Hospital: 1
• Primary Care Team: 13
• Budget (million €)
• 540 total
• 260 “capitation”
6. An introduction
Capitation
Concepts Expenses %
Personal costs 371.962.870,10 68,3%
Operating costs 110.761.052,67 20,4%
Arrendamientos 2.618.677,60 0,5%
Reparaciones 6.625.557,57 1,2%
Material oficina e informática 1.619.786,59 0,3%
Consumos energéticos, telefonía y ostales 9.416.549,05 1,7%
Vestuario y lencería 370.835,45 0,1%
Ptos. Farmacéuticos y de laboratorio 41.376.621,87 7,6%
Mat sanitario fungible 18.373.486,69 3,4%
Otros suministros de material 3.270.195,82 0,6%
Otros gastos 1.427.326,23 0,3%
Trabajos otras empresas 25.359.426,80 4,7%
Dietas personal 302.589,01 0,1%
Investments 6.189.361,29 1,1%
Concerts costs 30.399.165,41 5,6%
Prosthesis and stents costs 14.962.901,26 2,7%
Others costs 10.000.000,00 1,8%
Total 544.275.350,73 100,0%
7. Sumary
The introduction
The problem
The solution
Lessons & learnt
12. Sumary
The introduction
The problem
The solution
Lessons & learnt
13. Policies
Models
Best practices
Scientific evidence
14. Key elements
1. Identify and stratify population
2. Planning and coordinate care within all health care levels, using
case management methodology
3. Specific guidelines and protocols for each disease
4. Specific educational disease programmes
5. Integrated Information Systems
6. Evaluate and improve quality, cost and service
7. Align resources and incentives
15. Key elements
1. Identify and stratify population
2. Planning and coordinate care within all health care levels, using
case management methodology
3. Specific guidelines and protocols for each disease
4. Specific educational disease programmes
5. Integrated Information Systems
6. Evaluate and improve quality, cost and service
7. Align resources and incentives
16. Population stratification
5%
60% CASE MANAGEMENT
15%
DISEASE MANAGEMENT
80%
SELF CARE
40%
HEALTH PROMOTION AND DISEASE PREVENTION
17. Population stratification
Department LA FE: 260.000 population
≥ 3 admissions
2.500 15
CASE MANAGEMENT
13.000 75 ≤ 2 admissions
DISEASE MANAGEMENT
115.500 675 No admissions
SELF CARE
HEALTH PROMOTION AND DISEASE PREVENTION
18. Key elements
1. Identify and stratify population
2. Planning and coordinate care within all health care levels, using
case management methodology
3. Specific guidelines and protocols for each disease
4. Specific educational disease programmes
5. Integrated Information Systems
6. Evaluate and improve quality, cost and service
7. Align resources and incentives
19. The New Model
TRADITIONAL CARE MODEL CHRONIC CARE MODEL
Counsel re: Deal with
• Care is Proactive
Lifestyle Acute Attack
Review
Changes of Disease Reinforce • Care delivered by a health care
Labs team
Access Positive
Social/Other Health
Services Behaviours • Care integrated across time, place
Talk with and conditions
Reassure Family
• Care delivered in group
Complete
Diagnose
Forms
appointments, nurse clinics,
telephone, internet, e-mail, remote
General Consultation Review
Referral 10 minutes Care care technology
Plan
Reviwe/Adjus Review • Self-management support a
t Rx and Tx Routine Modify and/orHistory responsibility and integral part of the
Preventive Negotiate
Care Care Plans delivery system
20. The New Model
Sase Level 3 High complexity
management
60%
Level 2 High risk
Disease
management
self care
Level 1 Low risk
Self care
support/
management
40% Healthy promotion Level 0, Healthy
21. The New Model
Coordinated & Integrated Care
En resumen
Modelo de gestión de enfermedades crónicas del departamento La Fe de la Agencia Valenciana de Salud:
Actividades más importantes
Actor Nivel 3 Nivel 2 Nivel 1 Nivel 0
• Autocuidado
Pacient • Automonitorización Autocuidado, Autocuidado,
Primary Care
Paciente / Cuidador • Telemonitorización Automonitorización. Automonitorización. Hábitos de vida saludables
Carer • Uso adecuado de los recursos y de la
medicación
Telemonitorización Telemonitorización
• Formación e información • Formación e información • Formación e información
Primary
Equipo de Atención
• Atención domiciliaria y ambulatoria
programada y urgente
• Atención domiciliaria y
ambulatoria programada y
• Atención domiciliaria y
ambulatoria programada y
•
•
Formación e información
Atención domiciliaria y
Care
Primaria • Elaboración plan de cuidados con urgente urgente ambulatoria programada y
UHD • Comprobar inclusión en el • Comprobar inclusión en el urgente
• Comprobar inclusión en el programa programa programa
• Formación e información • Formación e información
Case
Gestora de casos
•
•
Seguimiento del paciente
Resolución de dudas del paciente
•
•
Seguimiento de 6 meses
Resolución de dudas
Manager • Coordinación con todos los recursos
asistenciales
• Coordinación recursos
asistenciales
• Formación en domicilio (3 dias) y
Hospital at
Unidad de
Hospitalización •
evaluación inicial del paciente
Elaborar el plan de cuidados con AP
•
•
Medico de enlace
Atención a domicilio en
Secundary Care
Home
Domiciliaria • Medico de enlace crsis de PP
DESCOMPENSACION
• Atencion a domicilio en crisis de PP
• Evaluación del riesgo de PP • Evaluación del riesgo de PP
• Atencion crisis de PP • Atencion crisis de PP
Acute Geriatric
Unidad Médica de
Corta Estancia
• Soporte a especialistas en la
asistencia de PP
• Soporte a especialistas en
la asistencia de PP
• Derivación de pacientes • Derivación de pacientes
• Información y formación al paciente • Seguimiento de la • Información y formación al
Specialist
Servicios • Seguimiento de la evolución del evolución del paciente paciente
Especialidad paciente • Atención en consulta • Atención en consulta
• Atención en consulta programada programada programada
09-30-00044-Departamento La Fe- Modelo de crónicos 02-VF4
–PP – Paciente Pluripatológico Página 96 de 142
24. Key elements
1. Identify and stratify population
2. Planning and coordinate care within all health care levels, using
case management methodology
3. Specific guidelines and protocols for each disease
4. Specific educational disease programmes
5. Integrated Information Systems
6. Evaluate and improve quality, cost and service
7. Align resources and incentives
26. Guidelines and protocols
Educative interventions
Factors that exacerbate disease
Exacerbation symptoms recognition
Knowledge about disease and treatment
Therapeutic compliance
27. Key elements
1. Identify and stratify population
2. Planning and coordinate care within all health care levels, using
case management methodology
3. Specific guidelines and protocols for each disease
4. Specific educational disease programmes
5. Integrated Information Systems
6. Evaluate and improve quality, cost and service
7. Align resources and incentives
31. Key elements
1. Identify and stratify population
2. Planning and coordinate care within all health care levels, using
case management methodology
3. Specific guidelines and protocols for each disease
4. Specific educational disease programmes
5. Integrated Information Systems
6. Evaluate and improve quality, cost and service
7. Align resources and incentives
32. Policies
Models
Best practices
Scientific evidence
33. The Results – “Pilots”
CASE
MANAGEMENT
DISEASE
MANAGEMENT
SELF CARE
HEALTH PROMOTION AND DISEASE PREVENTION
34. The results: CHF Pilot
Comparative analysis
RESOURCES Pre Manag
Average admissions CHF per patient 1,5 0,4 73,3%
Density admissions CHF 4,2 1,0 76,2%
Average stays per patient 11,4 2,6 77,2%
Density stays 43,9 8,6 80,4%
35. The results: CHF Pilot
Comparative analysis
RESOURCES Pre Manag
Average care atention all causes 3,6 1,4 61,1%
Average care atention CHF 1,9 0,4 78,9%
Density incidents urgency (all) 9,8 4,7 52,0%
Density incidents urgency (CHF) 5,3 1,3 75,5%
“Innovando los Cuidados de las Condiciones Crónicas”
36. The results: Palliative Care Pilot
Comparative analysis
RESULTS %
Exitus location at Home 74,2 %
Exitus location in Hospital 25,7 %
Sedation exitus at home 23,0 %
Hospital readmision 2,7 %
Derived to HML 3,4 %
“Innovando los Cuidados de las Condiciones Crónicas”
37. Key elements
1. Identify and stratify population
2. Planning and coordinate care within all health care levels, using
case management methodology
3. Specific guidelines and protocols for each disease
4. Specific educational disease programmes
5. Integrated Information Systems
6. Evaluate and improve quality, cost and service
7. Align resources and incentives
38. Align resources and incentives
Strategic Map - Departament Health LA FE
To guarantee services of health
A that satisfy the necessities and B To guarantee the economic
the expectations with the
sustainability of the system
population
Population and Society Patients Financials
C. To im prove the health results F. Improve the accessibility J. To m axim ize incom e
D. To generate confidence and security G. Lend decisive attendance and to m anage the investments
in the system H. Harness personalization K. To optim ize the costs
E. To respect environment I. Increase to fidelización and attraction L. Im prove the productivity
Promotion of the Suitable use of resources and Clinically Pioneering Development of
health optimized processes appropriate development of the the knowledge
attendance portfolio of services
1 To make the To harness the
promotion of 4 12 To orient
domiciliary attention 11 Potenciar
healthful and the 7 To harness 9 To innovate the investigation
docencia e
habits hospitalization clinical with the
investigación
security attention of
2 alternatives chronic activity in line
5
To present Rational use conditions
the system of diagnose 8 To impel the 10 12 To order
tests
3 Guarantee 6 To adapt use of the to innovate teaching to
the pharmaceutical best practices the portfolio of increase its
prevention prescription services impact
Improve the To align the
availability of the Impel the use To manage
investments 16
13 strategic 14 and security of 15 with the alliances with
intelligence the TIC agents nails
strategy
To develop the human potential
To incorporate
To orient the To implant a To plan the the To impel the
organization to System of 19 RR.HH for the 20 To improve the 21
sharpshooting 22 organizational
17 18 satisfaction of
the strategy Recognitions change professionals knowledge change
39. Align resources and incentives
.........................
MANAGEMENT
AGREEMENT
.........................
DEPARTAMENT LA FE 20%
Departamento de Salud nº 7
40. Align resources and incentives
PRIMARY CARE SECUNDARY CARE
Home
Care
Acute
Stay
Hospitalitation
Emergnecy
Emergency
Amulatory
Care
Ambulatorry Complex
Care
41. Align resources and incentives
SECUNDARY CARE
PRIMARY CARE
Case Managers
Acute Mediium & Long
Case Geriatric Stay
Home management Unit Unit
Care
Hospital
at Hospital Support Team
Home
Disease
Emergnecy management
Acute
Stay
Hospitalitation
Emergency
Ambulatorry Self care Ambulatoriy
Care support/ Care Amulatory
management Specialist Care
Complex
42. Align resources and incentives
Resources “care proactive” 2011
Primary Care Team
Doctor 1 / 1.500
Nurse 1 / 2.000
Hospital Home Unit Team
Doctor 1 / 20.000
Nurse 1 / 10.000
Case Managers * 1 / 125
*Chronic Level 1 High complex
43. Align resources and incentives
Resources “care reactive” 2011
Hospital Support Teams 2
Acute Geriatric Unit 45
Medium Stay Unit 56
Convalescence
Palliatives Care
Long Stay Unit 28
Mental Health Unit 28
“Innovando los Cuidados de las Condiciones Crónicas”
45. Align resources and incentives
e-CDM Service
5%
60% CASE MANAGEMENT
1.500 € year / user
15%
DISEASE MANAGEMENT
80%
SELF CARE
2.000 Case management
40%
HEALTH PROMOTION AND DISEASE PREVENTION
3.000.000 € year
46. Sumary
The introduction
The problem
The solution
Lessons & learnt
49. Align resources and incentives
e-CDM Service
5% 260.000 population
60% CASE MANAGEMENT
1.500 € year / user
15%
DISEASE MANAGEMENT
e-Health & e-Disease
80% 2.000 Case management
SELF CARE
Management
40%
HEALTH PROMOTION AND DISEASE PREVENTION
3.000.000 € year
3.000.000 € year
50. An introduction
Capitation
Concepts Expenses %
Personal costs 371.962.870,10 68,3%
Operating costs 110.761.052,67 20,4%
Arrendamientos 2.618.677,60 0,5%
Reparaciones 6.625.557,57 1,2%
Material oficina e informática 1.619.786,59 0,3%
Consumos energéticos, telefonía y ostales 9.416.549,05 1,7%
Vestuario y lencería 370.835,45 0,1%
↓ 10% Pharmaceutical and laboratory products 41.376.621,87 7,6%
health products and consumables 18.373.486,69 3,4%
Otros suministros de material 3.270.195,82 0,6%
Otros gastos 1.427.326,23 0,3%
Trabajos otras empresas 25.359.426,80 4,7%
Dietas personal 302.589,01 0,1%
Investments 6.189.361,29 1,1%
Concerts costs 30.399.165,41 5,6%
Prosthesis and stents costs 14.962.901,26 2,7%
Others costs 10.000.000,00 1,8%
Total 544.275.350,73 100,0%